Picture of Phio Pharmaceuticals logo

PHIO — Phio Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Phio Pharmaceuticals Corp expected to post a loss of 30  cents a share - Earnings Preview

* Phio Pharmaceuticals Corp  PHIO.OQ   PHIO.O  is expected
to report results on May 11 (estimated).
    * ​Refinitiv's mean analyst estimate for Phio
Pharmaceuticals Corp
is for a loss of 30 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Phio
Pharmaceuticals Corp is $6​, above​ its last closing price
of $0.85. ​​​

This summary was machine generated May 9 at 13:54 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Phio Pharmaceuticals

See all news